1In August, 988, Li Bogang borrowed 500,000 yuan, and applied the scientific research achievements of "Di 'ao Xinxuekang" he was responsible for to establish Chengdu Di 'ao Group. After 20 years of development, the net assets of Di 'ao Group have exceeded 4 billion yuan, the original investment has increased by 8,000 times, and the current annual output value has reached 654.38+06 billion yuan. Accumulated output value was 654.38+0.29 billion yuan, sales income was 654.38+0.25 billion yuan, and various taxes and fees paid to the state and local governments were 265.438+0.7 billion yuan. For eleven consecutive years, the total profit ranked first in the same industry in China, and the comprehensive economic benefits ranked first in the same industry in Sichuan for twelve consecutive years. Di 'ao Group ranks among the top 100 high-tech enterprises in China, and has been awarded the title of national innovative enterprise, listed as a national key high-tech enterprise and a national key Chinese patent medicine enterprise, and named as "Advanced High-tech Enterprise Implementing Torch Plan", the second national excellent enterprise in Chinese medicine industry and the outstanding enterprise in Sichuan Province. "Di 'ao" trademark was rated as a national well-known trademark.
The "Di 'ao Xinxuekang" developed by Li Bogang sells well all over the country and is exported overseas (20 12 entered the EU). It has been listed as a national essential drug, and the sales of famous and special new drugs, the consumption of similar drugs for cardiovascular diseases and the sales of therapeutic traditional Chinese medicines rank first. Accumulated output value of 7 billion yuan and sales income of 6.7 billion yuan. In recent years, Li Bogang has presided over the research and development of 10 high-tech new drugs.
Li Bogang led all scientific and technical personnel and workers to build Di 'ao into the world's largest manufacturer of high-purity steroidal saponins and high-purity thymosin, and established the world-leading national natural medicine engineering center, drug screening center and modernization system of traditional Chinese medicine. Di 'ao Group has applied for more than 0 independent innovation patents 100, 6 PCT international patents, and 30 independent innovation patents have been authorized by the state. Obtained new drug certificates 14, clinical approvals 1 1, and owned independent innovative drugs 10. Di 'ao Group has become a large-scale backbone pharmaceutical enterprise integrating natural drugs, drug synthesis, genetic engineering drugs, microbial drugs and pharmaceutical preparations, and is one of the most powerful drug research, pilot test and production bases in China.
Li Bogang's scientific research projects have won the third prize of National Science and Technology Progress Award, the first and second prizes of China Academy of Sciences and the first prize of Sichuan Science and Technology Progress Award. I have published more than 40 papers and 5 monographs. He has successively won young and middle-aged experts with outstanding contributions from China Academy of Sciences, advanced workers in major scientific research tasks of China Academy of Sciences during the Seventh Five-Year Plan period, winners of special allowances from the State Council, outstanding scientific and technological workers in Sichuan Province, national science and technology entrepreneur entrepreneurship award, national advanced workers, national top ten invention entrepreneurs, national top ten scientific and technological workers, outstanding entrepreneurs in Sichuan Province and so on.